The effect of intranasal fluticasone propionate irrigations on salivary cortisol, intraocular pressure, and posterior subcapsular cataracts in postsurgical chronic rhinosinusitis patients

International Forum of Allergy and Rhinology

Volumn 3, Issue 12, 2013, Pages 953-957

  Man, Li Xing ^a   Farhood, Zachary ^b   Luong, Amber ^b   Fakhri, Samer ^b   Feldman, Robert M ^b   Orlander, Philip R ^b   Citardi, Martin J ^b  

^a UNIVERSITY OF ROCHESTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Endoscopy; Quality of life; Sinusitis; Steroids; Topical

Indexed keywords

FLUTICASONE PROPIONATE; HYDROCORTISONE; SODIUM CHLORIDE;

ADRENAL FUNCTION; ADULT; ARTICLE; CHRONIC RHINOSINUSITIS; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG SAFETY; ENDOSCOPIC SINUS SURGERY; FEMALE; HUMAN; INTRAOCULAR PRESSURE; MALE; NASAL LAVAGE; OPEN STUDY; POSTERIOR SUBCAPSULAR CATARACT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SALIVA; SUBCAPSULAR CATARACT;

ENDOSCOPY; QUALITY-OF-LIFE; SINUSITIS; STEROIDS; TOPICAL;

ADULT; AGED; ANDROSTADIENES; CATARACT; CHRONIC DISEASE; FEMALE; HUMANS; HYDROCORTISONE; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; NASAL LAVAGE; PITUITARY-ADRENAL SYSTEM; PROSPECTIVE STUDIES; RHINITIS; SALIVA; SINUSITIS; TREATMENT OUTCOME;

EID: 84890425143     PISSN: 20426976     EISSN: 20426984     Source Type: Journal    
DOI: 10.1002/alr.21228     Document Type: Article

References (44)

1. Poetker DM, Reh DD. A comprehensive review of the adverse effects of systemic corticosteroids. Otolaryngol Clin North Am. 2010;43:753-768.
2. Venkatraman G, Likosky DS, Zhou W, Finlayson SR, Goodman DC. Trends in endoscopic sinus surgery rates in the Medicare population. Arch Otolaryngol Head Neck Surg. 2010;136:426-430.
3. Cullen KA, Hall MJ, Golosinskiy A. Ambulatory surgery in the United States, 2006. Natl Health Stat Report. 2009;(11):1-25.
4. Bhattacharyya N, Orlandi RR, Grebner J, Martinson M. Cost burden of chronic rhinosinusitis: a claims-based study. J Otolaryngol Head Neck Surg. 2011;144:440-445.
5. Harvey RJ, Goddard JC, Wise SK, Schlosser RJ. Effects of endoscopic sinus surgery and delivery device on cadaver sinus irrigation. J Otolaryngol Head Neck Surg. 2008;139:137-142.
6. Harvey RJ, Schlosser RJ. Local drug delivery. Otolaryngol Clin North Am. 2009;42:829-845, ix.
7. Kanowitz SJ, Batra PS, Citardi MJ. Topical budesonide via mucosal atomization device in refractory postoperative chronic rhinosinusitis. J Otolaryngol Head Neck Surg. 2008;139:131-136.
8. Bhalla RK, Payton K, Wright ED. Safety of budesonide in saline sinonasal irrigations in the management of chronic rhinosinusitis with polyposis: lack of significant adrenal suppression. J Otolaryngol Head Neck Surg. 2008;37:821-825.
9. Sachanandani NS, Piccirillo JF, Kramper MA, Thawley SE, Vlahiotis A. The effect of nasally administered budesonide respules on adrenal cortex function in patients with chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg. 2009;135:303-307.
10. Welch KC, Thaler ER, Doghramji LL, Palmer JN, Chiu AG. The effects of serum and urinary cortisol levels of topical intranasal irrigations with budesonide added to saline in patients with recurrent polyposis after endoscopic sinus surgery. Am J Rhinol Allergy. 2010;24:26-28.
11. Snidvongs K, Pratt E, Chin D, Sacks R, Earls P, Harvey RJ. Corticosteroid nasal irrigations after endoscopic sinus surgery in the management of chronic rhinosinusitis. Int Forum Allergy Rhinol. 2012;2:415-421.
12. Derendorf H, Meltzer EO. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications. Allergy. 2008;63:1292-1300.
13. Johnson M. Development of fluticasone propionate and comparison with other inhaled corticosteroids. J Allergy Clin Immunol. 1998;101:S434-S439.
14. U.S. Food and Drug Administration. Guidance for Industry. Allergic Rhinitis: Clinical Development Programs for Drug Products. Draft Guidance. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071293.pdf. Accessed September 18, 2013.
15. Chylack LT Jr, Wolfe JK, Singer DM, et al. The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol. 1993;111:831-836.
16. Smith CL, Kreutner W. In vitro glucocorticoid receptor binding and transcriptional activation by topically active glucocorticoids. Arzneimittelforschung. 1998;48:956-960.
17. Corren J. Intranasal corticosteroids for allergic rhinitis: how do different agents compare? J Allergy Clin Immunol. 1999;104:S144-S149.
18. Rhinocort Aqua [package insert]. Wilmington, DE: AstraZeneca LP, 2004.
19. Flonase [package insert]. Research Triangle Park, NC: GlaxoSmithKline, 2003.
20. Clark DJ, Grove A, Cargill RI, Lipworth BJ. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients. Thorax. 1996;51:262-266.
21. van As A, Bronsky E, Grossman J, Meltzer E, Ratner P, Reed C. Dose tolerance study of fluticasone propionate aqueous nasal spray in patients with seasonal allergic rhinitis. Ann Allergy. 1991;67:156-162.
22. Snidvongs K, Chaowanapanja P, Aeumjaturapat S, Chusakul S, Praweswararat P. Does nasal irrigation enter paranasal sinuses in chronic rhinosinusitis? Am J Rhinol. 2008;22:483-486.
23. Harvey RJ, Debnath N, Srubiski A, Bleier B, Schlosser RJ. Fluid residuals and drug exposure in nasal irrigation. J Otolaryngol Head Neck Surg. 2009;141:757-761.
24. Ahmet A, Kim H, Spier S. Adrenal suppression: A practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy. Allergy Asthma Clin Immunol. 2011;7:13.
25. Inder WJ, Dimeski G, Russell A. Measurement of salivary cortisol in 2012 - laboratory techniques and clinical indications. Clin Endocrinol (Oxf). 2012;77:645-651.
26. Deutschbein T, Broecker-Preuss M, Flitsch J, et al. Salivary cortisol as a diagnostic tool for Cushing's syndrome and adrenal insufficiency: improved screening by an automatic immunoassay. Eur J Endocrinol. 2012;166:613-618.
27. Ceccato F, Albiger N, Reimondo G, et al. Assessment of glucocorticoid therapy with salivary cortisol in secondary adrenal insufficiency. Eur J Endocrinol. 2012;167:769-776.
28. Mello RC, Sad EF, Andrade BC, et al. Serum and salivary cortisol in the diagnosis of adrenal insufficiency and as a predictor of the outcome in patients with severe sepsis. Arq Bras Endocrinol Metabol. 2011;55:455-459.
29. Estrada YMRM, Orlander PR. Salivary cortisol can replace free serum cortisol measurements in patients with septic shock. Chest. 2011;140:1216-1222.
30. Galbois A, Rudler M, Massard J, et al. Assessment of adrenal function in cirrhotic patients: salivary cortisol should be preferred. J Hepatol. 2010;52:839-845.
31. Perogamvros I, Owen LJ, Keevil BG, Brabant G, Trainer PJ. Measurement of salivary cortisol with liquid chromatography-tandem mass spectrometry in patients undergoing dynamic endocrine testing. Clin Endocrinol (Oxf). 2010;72:17-21.
32. van der Veen BS, Appelhof M, de Vries TW. Inhaled fluticasone propionate does not influence salivary cortisol when measured with tandem mass spectrometry. J Pediatr Endocrinol Metab. 2012;25:1217-1219.
33. Heijsman SM, de Vries TW, Wolthuis A, Kamps AW. Salivary cortisol levels in prepubertal children using inhaled corticosteroids with or without concurrent intranasal corticosteroids. Pediatr Pulmonol. 2011;46:1055-1061.
34. Bergmann J, Witmer MT, Slonim CB. The relationship of intranasal steroids to intraocular pressure. Curr Allergy Asthma Rep. 2009;9:311-315.
35. Bui CM, Chen H, Shyr Y, Joos KM. Discontinuing nasal steroids might lower intraocular pressure in glaucoma. J Allergy Clin Immunol. 2005;116:1042-1047.
36. Spiliotopoulos C, Mastronikolis NS, Petropoulos IK, Mela EK, Goumas PD, Gartaganis SP. The effect of nasal steroid administration on intraocular pressure. Ear Nose Throat J. 2007;86:394-395.
37. Ratner PH, Meltzer EO, Teper A. Mometasone furoate nasal spray is safe and effective for 1-year treatment of children with perennial allergic rhinitis. Int J Pediatr Otorhinolaryngol. 2009;73:651-657.
38. Ozkaya E, Ozsutcu M, Mete F. Lack of ocular side effects after 2 years of topical steroids for allergic rhinitis. J Pediatr Ophthalmol Strabismus. 2011;48:311-317.
39. Jick SS, Vasilakis-Scaramozza C, Maier WC. The risk of cataract among users of inhaled steroids. Epidemiology. 2001;12:229-234.
40. Wang JJ, Rochtchina E, Tan AG, Cumming RG, Leeder SR, Mitchell P. Use of inhaled and oral corticosteroids and the long-term risk of cataract. Ophthalmology. 2009;116:652-657.
41. Weatherall M, Clay J, James K, Perrin K, Shirtcliffe P, Beasley R. Dose-response relationship of inhaled corticosteroids and cataracts: a systematic review and meta-analysis. Respirology. 2009;14:983-990.
42. Cumming RG, Mitchell P, Leeder SR. Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med. 1997;337:8-14.
43. Derby L, Maier WC. Risk of cataract among users of intranasal corticosteroids. J Allergy Clin Immunol. 2000;105:912-916.
44. Liu A, Manche EE. Bilateral posterior subcapsular cataracts associated with long-term intranasal steroid use. J Cataract Refract Surg. 2011;37:1555-1558.